News Feature Channel: Neuro

Donation Fuels Research on DMT and its Potential Medical Use to Address Mental Health Conditions

University of California San Diego — Thu, 24 Apr 2025 21:35:12 EST

A gift from DMT Quest to UC San Diego will support research on the effects of the psychedelic DMT on the human brain, with potential to help treat depression, addiction and neurological conditions such as stroke.

Mayo Clinic Researchers Reveal Personalized Approach to Brain Cancer Monitoring

Mayo Clinic — Thu, 24 Apr 2025 09:10:43 EST

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most aggressive types of brain cancer. Their feasibility study suggests that a personalized blood test tailored to each patient's tumor DNA could provide a faster and less invasive way to determine if the cancer is advancing.

PatientIQ Partners with the AANS & AAOS to Launch EHR-Integrated Data Submission for the American Spine Registry (ASR)

American Association of Neurological Surgeons (AANS) — Thu, 24 Apr 2025 09:10:05 EST

PatientIQ, a leading health care technology company specializing in patient outcomes data, has expanded its support for national clinical registries with the launch of electronic health record (EHR)-integrated data submission for the American Spine Registry (ASR)--a collaborative effort between the American Association of Neurological Surgeons (AANS) and the American Association of Orthopaedic Surgeons (AAOS).

Even Light Exercise Could Help Slow Cognitive Decline in People at Risk of Alzheimer's

University of California San Diego — Thu, 24 Apr 2025 09:10:00 EST

In a landmark clinical trial, coordinated by the Alzheimer's Disease Cooperative Study at UC San Diego, people at risk for Alzheimer's who exercised at low or moderate-high intensity showed less cognitive decline when compared to those receiving usual care.

Immune Dysfunction and Inflammation Play Significant Role in Alzheimer's Disease

Alzheimer's Center at Temple University Lewis Katz School of Medicine — Wed, 23 Apr 2025 19:45:44 EST

Temple University, Philadelphia - Brain tissue analysis of an animal model reveals the potential role of immune system dysfunction in the onset and progression of Alzheimer's Disease (AD).

EXPLORER Total Body PET Scanner Helps Detect Brain Disease

UC Davis Health — Wed, 23 Apr 2025 19:05:59 EST

EXPLORER total body PET scanner is creating a new way to visualize the protective barrier to the brain to reveal impacts from cancer and other diseases.

مايو كلينك تكتشف تغيّرات في خلايا الدماغ قد تفسر متلازمة توريت

Mayo Clinic — Wed, 23 Apr 2025 18:15:39 EST

روتشستر، مينيسوتا -- كشفت دراسة جديدة من مايو كلينك أن الأشخاص المصابين بمتلازمة توريت يملكون عددًا أقل بنسبة تصل إلى 50٪ من نوع محدد من خلايا الدماغ التي تساعد في تهدئة الإشارات الحركية المفرطة، مقارنةً بالأشخاص غير المصابين. وقد يكون هذا النقص سببًا رئيسيًا في عدم كبح الإشارات الحركية، مما يؤدي إلى التشنجات اللاإرادية التي تُعد السمة المميزة لهذا الاضطراب.

Mayo Clinic revela cambios en las celulas cerebrales que podrian explicar el sindrome de Tourette

Mayo Clinic — Wed, 23 Apr 2025 17:50:23 EST

Un nuevo estudio de Mayo Clinic descubrio que las personas con sindrome de Tourette poseen aproximadamente la mitad de un tipo especifico de celula cerebral responsable de calmar los signos de movimiento hiperactivo, en comparacion con las personas sin la condicion. Este deficit puede ser una razon crucial por la cual las senales motoras no se controlan adecuadamente, lo que lleva a los tics involuntarios que caracterizan el trastorno.

Using a Pea-Sized Node in the Brain to Potentially Treat Drug Addiction

Rockefeller University — Wed, 23 Apr 2025 17:50:08 EST

Ines Ibanez-Tallon is revealing how an understudied region of the brain plays an outsized role in opioid and nicotine dependence.

Mayo Clinic revela alteracoes nas celulas cerebrais que podem explicar a sindrome de Tourette

Mayo Clinic — Wed, 23 Apr 2025 17:45:04 EST

Um novo estudo da Mayo Clinic descobriu que pessoas com sindrome de Tourette possuem cerca da metade de um tipo especifico de celula cerebral responsavel por acalmar os sinais de movimento hiperativo, em comparacao com pessoas sem a condicao. Esse deficit pode ser uma razao crucial pela qual os sinais motores nao sao controlados adequadamente, levando aos tiques involuntarios que caracterizam o transtorno.

Monell Center Presentations Span Sensory Science at National Meeting, April 23 to 26, 2025

Monell Chemical Senses Center — Wed, 23 Apr 2025 17:40:00 EST

Over 20 scientists from the Monell Chemical Senses Center will present their latest research at the 47th Association for Chemoreception Sciences annual conference, which covers the latest advances in the fields of taste, smell, and related chemical senses. Monell researchers are chairing and participating in oral presentation sessions as well as sharing close to 20 posters over three days. Several Monellians will also receive annual awards from AChemS for their research achievements, highlighted below.

Study Reveals Key Roles in Developmental Milestones of the Brain in Children

University of North Carolina School of Medicine — Wed, 23 Apr 2025 17:05:57 EST

Led by UNC School of Medicine's Weili Lin, PhD, researchers document cognitive milestones revealed in children from birth to toddlerhood in brain imaging study.

Metabolic Syndrome Linked to Increased Risk of Young-Onset Dementia

American Academy of Neurology (AAN) — Wed, 23 Apr 2025 16:00:00 EST

Having a larger waistline, high blood pressure and other risk factors that make up metabolic syndrome is associated with an increased risk of young-onset dementia, according to a study published on April 23, 2025, online in Neurology(r), the medical journal of the American Academy of Neurology.

The International League Against Epilepsy Updates Classification of Epileptic Seizures

International League Against Epilepsy — Wed, 23 Apr 2025 08:40:52 EST

The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework published in 2017. Six key changes were made. The updated classification now consists of four main classes and 21 seizure types, compared with 63 types previously.

Veravas Launches VeraBIND(tm) Tau - First Blood Test to Detect Alzheimer's-Related Tau Pathology

Veravas, Inc — Tue, 22 Apr 2025 20:15:59 EST

New non-invasive test offers 96% sensitivity and 90% specificity, empowering earlier and more accessible Alzheimer's detection

Trial Explores Drug-Free Approach to Treat ADHD Symptoms in Children Exposed to Alcohol Before Birth

University of California, Los Angeles (UCLA), Health Sciences — Tue, 22 Apr 2025 20:10:35 EST

Researchers at UCLA Health are launching the first clinical trial to test whether a wearable device that delivers gentle nerve stimulation during sleep could ease ADHD symptoms in children with prenatal alcohol exposure.

Multisequence 3-T Image Synthesis from 64-mT Low-Field-Strength MRI Using Generative Adversarial Networks in Multiple Sclerosis

Perelman School of Medicine at the University of Pennsylvania — Tue, 22 Apr 2025 20:00:18 EST

Mayo Clinic Uncovers Brain Cell Changes That Could Explain Tourette Syndrome

Mayo Clinic — Tue, 22 Apr 2025 17:50:51 EST

A new Mayo Clinic study finds that people with Tourette syndrome have about half as many of a specific type of brain cell that helps calm overactive movement signals as people without the condition. This deficit may be a key reason why their motor signals go unchecked, leading to the involuntary tics that define the disorder.

Seizure Action Plans: Management and Educational Tools in Epilepsy Care

International League Against Epilepsy — Tue, 22 Apr 2025 09:55:58 EST

Historically, seizure action plans have focused on certain high-risk groups of people with epilepsy. But some clinicians say that seizure action plans are important educational and seizure management tools that should be offered to everyone.

Plans d'action en cas de crise : plus que des outils de prise en charge de l'epilepsie

International League Against Epilepsy — Tue, 22 Apr 2025 09:40:09 EST

Historiquement, les plans d'action lors de la prise en charge d'une crise se sont concentres sur certains groupes de patients a haut risque, tels que les personnes atteintes d'epilepsie resistante aux medicaments et les personnes ayant des antecedents d'etat de mal epileptique ou de crises subintrantes.